timothy sykes logo

Stock News

Dentsply Sirona’s Restructuring to Yield Substantial Cost Savings

Bryce TuoheyAvatar
Written by Bryce Tuohey Reviewed by Tim Sykes Fact-checked by Matt Monaco
Updated 3/1/2026, 8:20 am ET 3/1/2026, 8:20 am ET | 5 min 5 min read
Dentsply Sirona’s Restructuring to Yield Substantial Cost Savings Thumbnail

FDA approval of innovative procedure propels DENTSPLY SIRONA Inc. stocks, trading up by 16.37 percent.

Healthcare industry expert:

Analyst sentiment – neutral

Dentsply Sirona (XRAY) currently faces a challenging market position characterized by negative profitability ratios, including an EBIT margin of -10.8% and a profit margin of -16.25%. Despite a respectable gross margin of 50%, the company struggles with consistent negative return on assets (-6.15%) and an elevated total debt to equity ratio of 1.81. The revenue has shown a downward trend over the past three years at -2.1%. Coupled with a lack of a positive P/E ratio, these indicators suggest significant financial distress. However, the company’s robust cash position and a current ratio of 1.5 reflect some measure of short-term financial stability.

In terms of technical analysis, Dentsply Sirona demonstrates a bullish weekly price momentum, with recent closing prices showing an increase from $12.8 to $14.79. The notable price rise on February 27th to $14.79 signals a potential upward breakout beyond the immediate resistance level of $14. Additionally, trading volumes appear supportive of this positive move, suggesting accumulative buying. The actionable trading strategy would be to enter long positions with an immediate target of $15.5, placing stop-loss orders below the recent low at $11.7714 to mitigate risk.

Recent catalysts for Dentsply Sirona include a restructuring plan projecting $120M in annualized savings and partnership expansion with Burkhart Dental Supply, which align with their Return-to-Growth Action Plan. The company’s focus on reinvesting savings and eliminating dividends suggests a strategic pivot towards growth. Despite recent underperformance in adjusted EPS, revenue beat expectations, signaling execution progress. With major analysts upgrading the stock and increasing price targets, there is cautious optimism in the market. Comparing to industry benchmarks, XRAY appears moderately undervalued but poised for recovery. I identify a key resistance at $17, with cautious optimism that expected restructuring benefits will materialize in improved fundamentals.

Candlestick Chart

Weekly Update Feb 23 – Feb 27, 2026: On Sunday, March 01, 2026 DENTSPLY SIRONA Inc. stock [NASDAQ: XRAY] is trending up by 16.37%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

The company has seen fluctuating stock prices, reaching as high as $14.79 recently, suggesting a volatile trading environment. The past week’s trading patterns reflect a rollercoaster ride, underscored by substantial swings in daily highs and lows. Dentsply Sirona’s revenue generation demonstrates robustness, evident from its Q4 revenue of $961M, which exceeded consensus forecasts. This revenue beat provides a positive outlook amidst otherwise challenging earnings metrics, such as an adjusted EPS of $0.27, falling short of the expected $0.29.

Key profitability ratios paint a less rosy picture, with negative performance indicators like an EBIT margin at -10.8% and a profit margin of -16.25%, suggesting an inefficient profit structure. The gross margin, however, stands at a healthy 50%, underlining strong core business operations. The firm’s financial strategies and forward-looking restructuring plans could meaningfully improve these metrics. Stakeholder confidence may have been boosted by strategic partnerships aimed at reducing operational inefficiencies.

Dentsply’s valuation measures and financial strength convey mixed signals. The PE ratio remains unspecified, yet investors note positive regard for the firm’s price-to-sales ratio of 0.69, reflecting undervaluation potential. With significant debt levels indicated by a total debt-to-equity ratio of 1.81, the delicacy of its financial position is clear. Cash flow statements reveal cash management and debt servicing as priorities, in step with its array of strategic moves.

More Breaking News

Conclusion

Dentsply Sirona is embarking on a journey of structural transformation. Its recent restructuring and capital allocation initiatives highlight a commitment to long-term profitability and operational efficacy. The partnership with Burkhart Dental Supply enhances distribution channels, portraying an aggressive market expansion strategy. The decision to abandon regular dividends in favor of share buybacks and debt reduction is a calculated move to solidify financial footing.

Despite execution challenges implied by mixed earnings—characterized by revenue outperformance yet subdued earnings per share—the overall outlook for Dentsply Sirona appears cautiously optimistic. As millionaire penny stock trader and teacher Tim Sykes, says, “Be patient, don’t force trades, and let the perfect setups come to you.” Thus, the company seems to be adopting a similar mindset, carefully evaluating market conditions rather than rushing into strategies that may not align with long-term goals. With the backing of major analysts through rating upgrades, paired with tangible strategic adaptions, the company may well navigate headwinds to forge a future growth trajectory. Expect close scrutiny from stakeholders as these developments unfold within the broader market landscape.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Bryce Tuohey

Mentor and Trainer at StocksToTrade.com, Lead Mentor at Small Cap Rockets and To The Moon Report
Bryce’s first pattern was buying into strength in breakouts. But he noticed when they didn’t work, he took bigger losses. When the OTC market got hot, Bryce learned to dip buy the inevitable panics. He adapted his breakout strategy and now buys consolidation and trend breaks. His goal is to have better risk/reward and get an entry before multi-day listed breakouts.
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”